Bristol Myers Squibb stock jumped after the pharma company won approval for its new schizophrenia drug late Thursday. “This ...

Thousands of plaintiffs have sued Ozempic manufacturers for failing to warn them about the risk of stomach paralysis.

The U.S. Food and Drug Administration approved Bristol Myers Squibb's schizophrenia drug late on Thursday, making it the ...

The Piper Cherokee emergency landing was executed perfectly on State Route 76 by 21-year-old Gabriel Breit at 1:40 a.m. but ...

Connecticut's Division of Criminal Justice failed to collect more than $43,000 forfeited by alleged drug dealers and others ...

Bristol-Myers Squibb shares rose in premarket trade on Friday after the Food and Drug Administration approved a schizophrenia ...

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.

The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...

The medication is the first in decades to have a different mode of action than do current drugs, achieving better symptom ...

The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia,  the FDA announced Thursday.

The Securities and Exchange Commission alleged that a researcher for the company manipulated trial data to make its drug ...

Two substances reacted during a demonstration involving commonly available chemicals found in illicit drug labs, according to ...